TY  - JOUR
AU  - Heumann, Philipp
AU  - Aguado-Barrera, Miguel E
AU  - Avuzzi, Barbara
AU  - Azria, David
AU  - Briers, Erik
AU  - Bultijnck, Renée
AU  - Choudhury, Ananya
AU  - De Ruysscher, Dirk
AU  - Farcy-Jacquet, Marie-Pierre
AU  - Fonteyne, Valérie
AU  - Gómez Caamaño, Antonio
AU  - Helmbold, Irmgard
AU  - Johnson, Kerstie
AU  - Kerns, Sarah L
AU  - Lambrecht, Maarten
AU  - Lingard, Zoe
AU  - Rancati, Tiziana
AU  - Rosenstein, Barry
AU  - Sperk, Elena
AU  - Paul Symonds, R.
AU  - Talbot, Christopher
AU  - Valdagni, Riccardo
AU  - Vega, Ana
AU  - Veldeman, Liv
AU  - Ward, Tim
AU  - Webb, Adam
AU  - West, Catharine
AU  - Chang-Claude, Jenny
AU  - Seibold, Petra
TI  - Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study.
JO  - Radiotherapy and oncology
VL  - 178
SN  - 0167-8140
CY  - Amsterdam [u.a.]
PB  - Elsevier Science
M1  - DKFZ-2022-02946
SP  - 109426
PY  - 2023
N1  - #EA:C020#LA:C020# / Volume 178, January 2023, 109426
AB  - Previous studies showed that healthcare professionals and patients had only moderate to low agreement on their assessment of treatment-related symptoms. We aimed to determine the levels of agreement in a large cohort of prostate cancer patients.Analyses were made of data from 1,756 prostate cancer patients treated with external beam radiotherapy (RT) and/or brachytherapy in Europe and the USA and recruited into the prospective multicentre observational REQUITE study. Eleven pelvic symptoms at the end of RT were compared after translating patient-reported outcomes (PROs) into CTCAE-based healthcare professional ratings. Gwet's AC2 agreement coefficient and 95
KW  - adverse events (Other)
KW  - agreement (Other)
KW  - patient-reported outcomes (Other)
KW  - prostate cancer (Other)
KW  - radiotherapy (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:36442608
DO  - DOI:10.1016/j.radonc.2022.11.015
UR  - https://inrepo02.dkfz.de/record/182814
ER  -